Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination - 03/09/21
Doi : 10.1016/j.jaci.2021.06.026
Mary M. Tomayko, MD, PhD a, b, ∗ 
, William Damsky, MD, PhD a, b, ∗, Ramie Fathy, BA c, Devon E. McMahon, MD d, i, Noel Turner, MD a, Monica N. Valentin, MD e, Tena Rallis, MD f, Ohara Aivaz, MD g, Lindy P. Fox, MD h, Esther E. Freeman, MD, PhD d, j
, William Damsky, MD, PhD a, b, ∗, Ramie Fathy, BA c, Devon E. McMahon, MD d, i, Noel Turner, MD a, Monica N. Valentin, MD e, Tena Rallis, MD f, Ohara Aivaz, MD g, Lindy P. Fox, MD h, Esther E. Freeman, MD, PhD d, j a Department of Dermatology, Yale University School of Medicine, New Haven, Conn
b Department of Pathology, Yale University School of Medicine, New Haven, Conn
c Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa
d Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
e Anne Arundel Dermatology, Fairfax, Va
f HVMA/Atrius Health, Peabody, Mass
g Cedars-Sinai Medical Group, Department of Dermatology, Beverly Hills, Calif
h Department of Dermatology, University of California, San Francisco, Calif
i Harvard Medical School, Boston, Mass
j Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
| The American Academy of Dermatology/International League of Dermatological Societies COVID-19 Dermatology Registry is supported by a grant from the International League of Dermatologic Societies to Massachusetts General Hospital and by in-kind support from the American Academy of Dermatology. Dr Damsky is supported by a Career Development Award from the Dermatology Foundation. |
|
| Disclosure of potential conflict of interest: E. E. Freeman and L. P. Fox are part of the American Academy of Dermatology Ad Hoc Task Force on COVID-19 (unpaid). E. E. Freeman is the principal investigator of the COVID-19 Dermatology Registry, and she is a coauthor for UpToDate on COVID-19 Dermatology. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2021
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 148 - N° 3
P. 750-751 - septembre 2021 Retour au numéro
Article précédent
- Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
- David Hagin, Tal Freund, Michal Navon, Tami Halperin, Dikla Adir, Rotem Marom, Inbar Levi, Shira Benor, Yifat Alcalay, Natalia T. Freund
- Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3
- James G. Krings, Charles W. Goss, Daphne Lew, Maanasi Samant, Mary Clare McGregor, Jonathan Boomer, Leonard B. Bacharier, Ajay Sheshadri, Chase Hall, Joshua Brownell, Ken B. Schechtman, Samuel Peterson, Stephen McEleney, David T. Mauger, John V. Fahy, Sean B. Fain, Loren C. Denlinger, Elliot Israel, George Washko, Eric Hoffman, Sally E. Wenzel, Mario Castro, National Heart, Lung, and Blood Institute’s Severe Asthma Research Program Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.